Scientists at Sichuan University ’s West University Hospital in Chengdu are set to be the first to inject people with T cells modified by the CRISPR – Cas9 gene - editing technique . The technique will be tested next month on lung cancer patients for whom surgery , radiation therapy and other treatments have failed . Oncologist Lu You 's team will release gene - edited cells back into the patient 's bloodstream which will then home in on the cancer . The Phase 1 trial is designed to determine whether the technique is safe .
Scientists at Sichuan University’s West China Hospital in Chengdu are set to be the first to inject people with T cells modified by the CRISPR–Cas9 gene-editing technique. The cells will be tested next month on lung cancer patients for whom chemotherapy, radiation therapy and other treatments have failed. Oncologist Lu You's team will reintroduce gene-edited cells back into the patient's bloodstream which will then home in on the cancer. The phase 1 trial is designed to determine whether the technique is safe.